232 related articles for article (PubMed ID: 17889263)
1. Haplotype-based analysis of genes associated with risk of adverse skin reactions after radiotherapy in breast cancer patients.
Suga T; Ishikawa A; Kohda M; Otsuka Y; Yamada S; Yamamoto N; Shibamoto Y; Ogawa Y; Nomura K; Sho K; Omura M; Sekiguchi K; Kikuchi Y; Michikawa Y; Noda S; Sagara M; Ohashi J; Yoshinaga S; Mizoe J; Tsujii H; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):685-93. PubMed ID: 17889263
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy.
Ishikawa A; Suga T; Shoji Y; Kato S; Ohno T; Ishikawa H; Yoshinaga S; Ohara K; Ariga H; Nomura K; Shibamoto Y; Ishikawa K; Moritake T; Michikawa Y; Iwakawa M; Imai T
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1144-52. PubMed ID: 21050672
[TBL] [Abstract][Full Text] [Related]
3. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
De Ruyck K; Van Eijkeren M; Claes K; Morthier R; De Paepe A; Vral A; De Ridder L; Thierens H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1140-9. PubMed ID: 15990020
[TBL] [Abstract][Full Text] [Related]
4. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients.
Chang-Claude J; Popanda O; Tan XL; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Ambrosone CB
Clin Cancer Res; 2005 Jul; 11(13):4802-9. PubMed ID: 16000577
[TBL] [Abstract][Full Text] [Related]
5. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients.
Terrazzino S; La Mattina P; Gambaro G; Masini L; Franco P; Canonico PL; Genazzani AA; Krengli M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):504-11. PubMed ID: 22079734
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
7. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
8. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
9. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
10. The XRCC1 -77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage.
Brem R; Cox DG; Chapot B; Moullan N; Romestaing P; Gérard JP; Pisani P; Hall J
Carcinogenesis; 2006 Dec; 27(12):2469-74. PubMed ID: 16829685
[TBL] [Abstract][Full Text] [Related]
11. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
Moullan N; Cox DG; Angèle S; Romestaing P; Gérard JP; Hall J
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1168-74. PubMed ID: 14652276
[TBL] [Abstract][Full Text] [Related]
13. A role for XRCC4 in age at diagnosis and breast cancer risk.
Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
[TBL] [Abstract][Full Text] [Related]
14. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk.
Frank B; Hemminki K; Shanmugam KS; Meindl A; Klaes R; Schmutzler RK; Wappenschmidt B; Untch M; Bugert P; Bartram CR; Burwinkel B
Carcinogenesis; 2005 Nov; 26(11):1975-7. PubMed ID: 15975957
[TBL] [Abstract][Full Text] [Related]
15. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients.
Quarmby S; Fakhoury H; Levine E; Barber J; Wylie J; Hajeer AH; West C; Stewart A; Magee B; Kumar S
Int J Radiat Biol; 2003 Feb; 79(2):137-43. PubMed ID: 12569017
[TBL] [Abstract][Full Text] [Related]
16. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors.
De Ruyck K; Van Eijkeren M; Claes K; Bacher K; Vral A; De Neve W; Thierens H
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1240-8. PubMed ID: 16798416
[TBL] [Abstract][Full Text] [Related]
17. A systematic assessment of common genetic variation in CYP11A and risk of breast cancer.
Setiawan VW; Cheng I; Stram DO; Giorgi E; Pike MC; Van Den Berg D; Pooler L; Burtt NP; Le Marchand L; Altshuler D; Hirschhorn J; Henderson BE; Haiman CA
Cancer Res; 2006 Dec; 66(24):12019-25. PubMed ID: 17178901
[TBL] [Abstract][Full Text] [Related]
18. Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity.
Zschenker O; Raabe A; Boeckelmann IK; Borstelmann S; Szymczak S; Wellek S; Rades D; Hoeller U; Ziegler A; Dikomey E; Borgmann K
Radiother Oncol; 2010 Oct; 97(1):26-32. PubMed ID: 20170971
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the Janus kinase 2 (JAK)/signal transducer and activator of transcription (STAT) genes: putative association of the STAT gene region with familial breast cancer.
Vaclavicek A; Bermejo JL; Schmutzler RK; Sutter C; Wappenschmidt B; Meindl A; Kiechle M; Arnold N; Weber BH; Niederacher D; Burwinkel B; Bartram CR; Hemminki K; Försti A
Endocr Relat Cancer; 2007 Jun; 14(2):267-77. PubMed ID: 17639043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
